Welcome to LookChem.com Sign In|Join Free

CAS

  • or

26607-15-8

Post Buying Request

26607-15-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

26607-15-8 Usage

Definition

ChEBI: A dipeptide composed of L-leucine and L-arginine joined by peptide linkages.

Check Digit Verification of cas no

The CAS Registry Mumber 26607-15-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,6,0 and 7 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 26607-15:
(7*2)+(6*6)+(5*6)+(4*0)+(3*7)+(2*1)+(1*5)=108
108 % 10 = 8
So 26607-15-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H25N5O3/c1-7(2)6-8(13)10(18)17-9(11(19)20)4-3-5-16-12(14)15/h7-9H,3-6,13H2,1-2H3,(H,17,18)(H,19,20)(H4,14,15,16)

26607-15-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name H-LEU-ARG-OH

1.2 Other means of identification

Product number -
Other names leucinyl arginine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:26607-15-8 SDS

26607-15-8Downstream Products

26607-15-8Relevant articles and documents

Antiviral Immunotropic Agent for the Treatment of Acute Respiratory Viral Infections

-

Paragraph 0058; 0060, (2019/11/05)

The proposed methods of treatment pertain to medicine, in particular pharmacology, and concerns the application of a nasal medicinal composition containing hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine or its pharmaceutically acceptable

Bradykinin antagonists

-

, (2008/06/13)

A bradykinin antagonist of the formula wherein BKA is the peptide chain of a bradykinin antagonist peptide, X is a linking group and n is a whole number greater than 1. The BKA substituents may be the same or different. Monomeric antagonists of the formula X(BKA) are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 26607-15-8